- Home
- HCTI vs INM Comparison
HCTI vs INM Comparison
Compare HCTI & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HCTI
- INM
- Stock Information
- Founded
- HCTI 2020
- INM 1981
- Country
- HCTI United States
- INM Canada
- Employees
- HCTI 33
- INM N/A
- Industry
- HCTI Retail: Computer Software & Peripheral Equipment
- INM Biotechnology: Pharmaceutical Preparations
- Sector
- HCTI Technology
- INM Health Care
- Exchange
- HCTI Nasdaq
- INM Nasdaq
- Market Cap
- HCTI 2.2M
- INM 2.3M
- IPO Year
- HCTI 2021
- INM N/A
- Fundamental
- Price
- HCTI $0.40
- INM $3.12
- Analyst Decision
- HCTI
- INM
- Analyst Count
- HCTI 0
- INM 0
- Target Price
- HCTI N/A
- INM N/A
- AVG Volume (30 Days)
- HCTI 3.9M
- INM 84.1K
- Earning Date
- HCTI 03-17-2025
- INM 02-12-2025
- Dividend Yield
- HCTI N/A
- INM N/A
- EPS Growth
- HCTI N/A
- INM N/A
- EPS
- HCTI N/A
- INM N/A
- Revenue
- HCTI $16,565,999.00
- INM $4,832,013.00
- Revenue This Year
- HCTI $88.31
- INM N/A
- Revenue Next Year
- HCTI N/A
- INM N/A
- P/E Ratio
- HCTI N/A
- INM N/A
- Revenue Growth
- HCTI N/A
- INM N/A
- 52 Week Low
- HCTI $0.29
- INM $2.42
- 52 Week High
- HCTI $2.96
- INM $15.70
- Technical
- Relative Strength Index (RSI)
- HCTI 36.76
- INM 37.82
- Support Level
- HCTI $0.43
- INM $3.03
- Resistance Level
- HCTI $0.88
- INM $3.48
- Average True Range (ATR)
- HCTI 0.10
- INM 0.20
- MACD
- HCTI -0.02
- INM 0.05
- Stochastic Oscillator
- HCTI 0.00
- INM 35.59
About HCTI Healthcare Triangle Inc.
Healthcare Triangle Inc is a healthcare information technology company focused on advancing industry-transforming solutions in the sectors of cloud services, data science, and professional and managed services for the healthcare and life sciences industry. The company reinforces healthcare progress through technology and extensive industry know-how. HTI supports healthcare providers and payors, hospitals, and Pharma Life Sciences organizations in their effort to improve health outcomes by enabling the adoption of new technologies, data enlightenment, business agility, and accelerated response to immediate business needs and competitive threats. It provides services under three operating segments which are Software Services, Managed Services, and Support and Platform Services.
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.